Ted Okon, MBA, and Bruce Feinberg, DO, further discuss why end-of-life care for patients with cancer remains so challenging. Dr Feinberg notes that data now reveal an increase in intensive care unit use during the last month of a patient’s life, and larger numbers of patients being referred to hospice for 3 days or less.
In an effort to close gaps in end-of-life care and address patients’ advanced care planning concerns, accountable care organizations are now integrating palliative care physicians and nurses into oncology practices, explains Brian Kiss, MD. “They are integrating palliative care into the practice and into their processes from the beginning and that’s kind of an encouraging element,” says Dr Kiss.
However, Dr Feinberg highlights reasons why these changes may become problematic. Dr Feinberg explains that ACOs utilize a different reimbursement structure. Additionally, he is concerned that because palliative care physicians and nurses generate less income than medical oncologists, financial matters may impede the effects of these professionals to work as equal partners.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Lack of Mutations Associated With Favorable Prognosis in MPN-U
April 25th 2024While the Dynamic International Prognostic Scoring System and bone marrow blasts may predict overall survival, the lack of certain mutations is also associated with a better prognosis for myeloproliferative neoplasm, unclassifiable (MPN-U).
Read More